-
April 10, 2013
Health systems around the world are increasingly negotiating secret price rebates from pharmaceutical companies, and Canada risks losing out on these deals, new research warns.
Full story
-
July 02, 2012
2011 marks the ninth consecutive year that member companies of Canada's Research-Based Pharmaceutical Companies (Rx&D) have broken their promise to spend at least 10% of their domestic sales on R&D, says a government report.
Full story
-
May 29, 2012
A leading US Senator has called for more details of the $20 million contract recently awarded by the Department of Health and Human Services (HHS) to a public relations firm to advertise President Barack Obama's Affordable Care Act (ACA).
Full story
-
March 08, 2012
US drugmakers have rejected new claims that, even with big declines in generic drug prices, the average annual cost paid by seniors for their prescription drug therapy increased more than $1,000 during 2005-2009.
Full story
-
October 11, 2011
A doctors' leader has warned that GPs could protest against the government's planned pension reforms by refusing to prescribe generic drugs, and that this would "blow budgets out of the sky within a month."
Full story
-
July 29, 2011
US spending on prescription drugs will rise sharply to 10.7% in 2014, which is 5.1 percentage points - and $15.8 billion - more than it would have done without the Patient Protection and Affordable Care Act, say new official forecasts.
Full story